Saoirse Dolly

COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study

Lennard Y. W. Lee, Jean‐Baptiste Cazier, Thomas Starkey et al. · The Lancet Oncology · 2020 · 599 citations · Full text

Primary Tumour Subtype, Epidemiology, Cancer Epidemiology +11

First-in-Human, Phase I Dose-Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of RO5126766, a First-in-Class Dual MEK/RAF Inhibitor in Patients with Solid Tumors

Maria Martinez‐García, Udai Banerji, Joan Albanell et al. · Clinical Cancer Research · 2012 · 151 citations

Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study

David J. Pinato, Josep Tabernero, Mark Bower et al. · The Lancet Oncology · 2021 · 134 citations · Full text

Registry Study, Viral Persistence, Sars-cov-2 Infection +8

Phase I Study of Apitolisib (GDC-0980), Dual Phosphatidylinositol-3-Kinase and Mammalian Target of Rapamycin Kinase Inhibitor, in Patients with Advanced Solid Tumors

Saoirse Dolly, Andrew J. Wagner, Johanna C. Bendell et al. · Clinical Cancer Research · 2016 · 131 citations · Full text

Factor H, a regulator of complement activity, is a major determinant of meningococcal disease susceptibility in UK Caucasian patients

Elene Haralambous, Saoirse Dolly, Martin L. Hibberd et al. · Scandinavian Journal of Infectious Diseases · 2006 · 75 citations